Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
HERON THERAPEUTICS, INC. (HRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 692 shares
@ $1.65, valued at
$1.1k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $1.31, valued at
$2.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 860 shares
@ $1.31, valued at
$1.1k
Exercised 552 restricted stock units
@ $0
Exercised 1,933 restricted stock units
@ $0 |
|
| 05/24/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 691 shares
@ $1.45, valued at
$1k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Collard Craig A (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 3,000,000 options to buy
@ $1.78, valued at
$5.3M
Granted 250,000 restricted stock units
@ $0
Granted 4,250,000 options to buy
@ $1.78, valued at
$7.6M
|
|
| 02/24/2023 |
4
| Morgan Adam (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 37,879 shares
@ $0
Granted 227,272 options to buy
@ $2.7, valued at
$613.6k
|
|
| 01/20/2023 |
4
| Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 49,788 rights
@ $0 |
|
| 01/20/2023 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 850,000 options to buy
@ $3.13, valued at
$2.7M
|
|
| 01/20/2023 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 66,385 rights
@ $0 |
|
| 01/20/2023 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 42,631 rights
@ $0 |
|
| 01/20/2023 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 149,365 rights
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Christian Waage (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 38,580 shares
@ $0
Granted 77,160 options to buy
@ $2.74, valued at
$211.4k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Johnson Craig A (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 38,580 shares
@ $0
Granted 77,160 options to buy
@ $2.74, valued at
$211.4k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 38,580 shares
@ $0
Granted 77,160 options to buy
@ $2.74, valued at
$211.4k
|
|
| 10/17/2022 |
4
| Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $3.76, valued at
$7.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 10/17/2022 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 5,219 shares
@ $3.76, valued at
$19.6k
Exercised 3,646 restricted stock units
@ $0
Exercised 16,122 restricted stock units
@ $0 |
|
| 10/17/2022 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $3.76, valued at
$7.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 10/17/2022 |
4
| Peraza Lisa (VP, Chief Accounting Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 861 shares
@ $3.76, valued at
$3.2k
Exercised 553 restricted stock units
@ $0
Exercised 1,932 restricted stock units
@ $0 |
|
| 10/17/2022 |
4
| MANHARD KIMBERLY (EVP, Drug Development) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $3.76, valued at
$7.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 07/27/2022 |
4
| Szekeres David Leslie (EVP, COO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 165,961 options to buy
@ $3.17, valued at
$526.1k
|
|
| 07/27/2022 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 165,961 options to buy
@ $3.17, valued at
$526.1k
|
|
|
|
|